• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EXACTECH, INC. OPTETRAK HI-FLEX TIBIAL INSERT SZ 5 9MM; PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EXACTECH, INC. OPTETRAK HI-FLEX TIBIAL INSERT SZ 5 9MM; PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED Back to Search Results
Catalog Number 244-25-09
Medical Device Problem Codes Unstable (1667); Naturally Worn (2988); Insufficient Device Problem Information (3190)
Health Effect - Clinical Codes Synovitis (2094); Osteolysis (2377); Inadequate Osseointegration (2646); Joint Laxity (4526)
Date of Event 12/14/2022
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Pending investigation.
 
Event or Problem Description
As reported via legal documentation, a patient had bilateral knee replacement on 21 feb 2006.They underwent left knee revision surgery on (b)(6) 2022, approximately 16 years 10 months post primary procedure.(b)(6) 2022 op report postoperative diagnosis: periprosthetic osteolysis of internal prosthetic left knee joint.The surgeon noted a moderate amount of reactive synovitis with hemosiderin staining of the synovium consistent with polyethylene wear and instability.The femoral component did not appear grossly loose, but was easily explanted with gentle disimpaction.There was nearly complete de-bonding of the femoral component with minimal evidence of an implant-cement interface.Tibial component was noted as well-fixed.Surgeon further noted there was a large contained central defect secondary to osteolysis as anticipated based on preoperative ct.Patellar component was determined to be loose.The patient emerged from anesthesia and was transferred to the pacu in stable condition.There is no other patient demographic or medical history available.There is no device return.There are no photos or other images of the device provided.No additional information is available.
 
Additional Manufacturer Narrative
The reason for the revision reported cannot be confirmed from the information provided but may be the result of prosthesis wear and patellar loosening or due to inclusion of the polyethylene in the packaging recall.Additionally, these devices appear to have been implanted for over ten years prior to the reported event.Potential contributions of user and patient-related considerations to the event could not be assessed as the devices were not available for evaluation and images and radiographs were not provided.H6: corrected health effect, medical device, component, and investigation clinical codes.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTETRAK HI-FLEX TIBIAL INSERT SZ 5 9MM
Common Device Name
PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED
Manufacturer (Section D)
EXACTECH, INC.
2320 nw 66 court
gainesville FL 32653
Manufacturer (Section G)
EXACTECH, INC.
2320 nw 66th ct.
gainesville FL 32653
Manufacturer Contact
geoff gannon
gainesville 32653
3523782617
MDR Report Key17461605
Report Number1038671-2023-01861
Device Sequence Number12571959
Product Code JWH
UDI-Device Identifier10885862064073
UDI-Public10885862064073
Combination Product (Y/N)N
Initial Reporter StateFL
Initial Reporter CountryUS
PMA/510(K) Number
K033883
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2006
Device Explanted Year2022
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Company Representative
Initial Reporter Occupation Non-Healthcare Professional
Remedial Action Recall
Type of Report Initial,Followup
Report Date (Section B) 01/09/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Expiration Date08/31/2010
Device Catalogue Number244-25-09
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/07/2023
Supplement Date Received by Manufacturer01/09/2025
Initial Report FDA Received Date08/04/2023
Supplement Report FDA Received Date01/09/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured09/01/2005
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
If action reported to FDA under 21 USC 360i(g), list
FDA-assigned Recall Number or include a statement
Z-0019-2022
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age79 YR
Patient SexMale
-
-